MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$705,775
(-136.38%↓ Y/Y)
Foreign currency
translation gain
$3,216
Net loss
attributable to common...
-$708,991
(47.30%↑ Y/Y)
Trading Of Industrial
Chemicals
$2,539,055
Screening Services And
Related Sales
$4,768
Loss before tax
-$708,991
(47.24%↑ Y/Y)
Revenue (including
25,649 and 23,456 of...
$2,543,823
(-3.29%↓ Y/Y)
Gain on disposal of
investments in equity...
$42,376
Others
$40,414
(-91.32%↓ Y/Y)
Interest income
$20,778
Dividend income
$4,192
Loss from operations
-$702,509
(47.48%↑ Y/Y)
Finance costs
$6,482
Gross profit
$377,685
(15.66%↑ Y/Y)
Total other income
$107,760
Cost of revenue
(including 7,233 and...
$2,166,138
(-5.98%↓ Y/Y)
Total operating
expenses
$1,187,954
Sales and marketing
$551,569
General and
administrative (including...
$445,691
(-79.07%↓ Y/Y)
Provision for expected
credit losses
$175,818
Research and development
$14,876
Back
Back
Income Statement
source: myfinsight.com
BioNexus Gene Lab Corp (BGLC)
BioNexus Gene Lab Corp (BGLC)